Sean Teare, President of InnovationRx stated, "We are thrilled to be working with InforMedix to uniquely combine our proprietary assessment and behavioral modification techniques and technologies, anchored in pharmacist-based call centers, with InforMedix's real-time prompting, monitoring, reporting, and automatic outbound alerting when patients miss their medications, or their health status is declining. Med-eXpert's detailed Web-enabled reports for each patient, graphically depicting their reasons for non-adherence (e.g. side effects, ran out of medications, change in doctors' orders, etc.), will enhance the consulting effectiveness of our pharmacists.
Bruce A. Kehr, M.D., chairman and Chief Executive Officer of InforMedix
commented "What is really exciting about our plans with InnovationRx is
that through combining their products and services with our own, we offer
the marketplace an end-to-end solution that first assesses risk of patient
non-adherence, and then assigns that patient exactly what products and
services they need to optimize adherence and health. The addition of risk
assessment algorithms, and pharmacist-based call centers receiving
real-time adherence and health status data from our Med-eXpert database,
from patients using our Med-ePhone or Med-eMonitor, powerfully completes a
comprehensive medication adherence solution that is unique to the
marketplace. We believe that by working together with InnovationRx, backed
by the global reach of their parent, Innovation Group, we can sign
|SOURCE InforMedix Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved